These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24806967)

  • 1. Innate immunity in the vagina (Part II): Anti-HIV activity and antiviral content of human vaginal secretions.
    Patel MV; Ghosh M; Fahey JV; Ochsenbauer C; Rossoll RM; Wira CR
    Am J Reprod Immunol; 2014 Jul; 72(1):22-33. PubMed ID: 24806967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.
    Hughes BL; Dutt R; Raker C; Barthelemy M; Rossoll RM; Ramratnam B; Wira CR; Cu-Uvin S
    Am J Obstet Gynecol; 2016 Dec; 215(6):748.e1-748.e12. PubMed ID: 27393267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of menopause on the innate antiviral activity of cervicovaginal lavage.
    Chappell CA; Isaacs CE; Xu W; Meyn LA; Uranker K; Dezzutti CS; Moncla BJ; Hillier SL
    Am J Obstet Gynecol; 2015 Aug; 213(2):204.e1-6. PubMed ID: 25818668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.
    Ghosh M; Fahey JV; Shen Z; Lahey T; Cu-Uvin S; Wu Z; Mayer K; Wright PF; Kappes JC; Ochsenbauer C; Wira CR
    PLoS One; 2010 Jun; 5(6):e11366. PubMed ID: 20614007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immunity in the vagina (part I): estradiol inhibits HBD2 and elafin secretion by human vaginal epithelial cells.
    Patel MV; Fahey JV; Rossoll RM; Wira CR
    Am J Reprod Immunol; 2013 May; 69(5):463-74. PubMed ID: 23398087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced levels of genital tract immune biomarkers in postmenopausal women: implications for HIV acquisition.
    Jais M; Younes N; Chapman S; Cu-Uvin S; Ghosh M
    Am J Obstet Gynecol; 2016 Sep; 215(3):324.e1-324.e10. PubMed ID: 27026477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential profiles of immune mediators and in vitro HIV infectivity between endocervical and vaginal secretions from women with Chlamydia trachomatis infection: a pilot study.
    Sperling R; Kraus TA; Ding J; Veretennikova A; Lorde-Rollins E; Singh T; Lo Y; Quayle AJ; Chang TL
    J Reprod Immunol; 2013 Sep; 99(1-2):80-7. PubMed ID: 23993451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study.
    Masson L; Barnabas S; Deese J; Lennard K; Dabee S; Gamieldien H; Jaumdally SZ; Williamson AL; Little F; Van Damme L; Ahmed K; Crucitti T; Abdellati S; Bekker LG; Gray G; Dietrich J; Jaspan H; Passmore JS
    Sex Transm Infect; 2019 Feb; 95(1):5-12. PubMed ID: 30018088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human epididymis protein 4 and secretory leukocyte protease inhibitor in vaginal fluid: relation to vaginal components and bacterial composition.
    Orfanelli T; Jayaram A; Doulaveris G; Forney LJ; Ledger WJ; Witkin SS
    Reprod Sci; 2014 Apr; 21(4):538-42. PubMed ID: 24023032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding.
    Al-Harthi L; Kovacs A; Coombs RW; Reichelderfer PS; Wright DJ; Cohen MH; Cohn J; Cu-Uvin S; Watts H; Lewis S; Beckner S; Landay A;
    AIDS; 2001 Aug; 15(12):1535-43. PubMed ID: 11504986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Follicular and Luteal Phase Mucosal Markers of HIV Susceptibility in Healthy Women.
    Thurman AR; Chandra N; Yousefieh N; Zalenskaya I; Kimble T; Asin S; Rollenhagen C; Anderson SM; Herold B; Mesquita PM; Richardson-Harman N; Cunningham T; Schwartz JL; Doncel GF
    AIDS Res Hum Retroviruses; 2016 Jun; 32(6):547-60. PubMed ID: 26750085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cataloguing of Potential HIV Susceptibility Factors during the Menstrual Cycle of Pig-Tailed Macaques by Using a Systems Biology Approach.
    Vishwanathan SA; Burgener A; Bosinger SE; Tharp GK; Guenthner PC; Patel NB; Birse K; Hanson DL; Westmacott GR; Henning TR; Radzio J; Garcia-Lerma JG; Ball TB; McNicholl JM; Kersh EN
    J Virol; 2015 Sep; 89(18):9167-77. PubMed ID: 26109722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulins in human cervico-vaginal secretions.
    Jalanti R; Isliker H
    Int Arch Allergy Appl Immunol; 1977; 53(5):402-8. PubMed ID: 558170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretions.
    Villanueva JM; Ellerbrock TV; Lennox JL; Bush TJ; Wright TC; Pratt-Palmore M; Evans-Strickfaden T; Conley LJ; Schnell C; Hart CE
    J Infect Dis; 2002 Jan; 185(2):170-7. PubMed ID: 11807690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Cationic Proteins Are Associated with HIV Neutralizing Activity in Genital Secretions of Female Sex Workers.
    Birse KD; Cole AL; Hirbod T; McKinnon L; Ball TB; Westmacott GR; Kimani J; Plummer F; Cole AM; Burgener A; Broliden K
    PLoS One; 2015; 10(6):e0130404. PubMed ID: 26090884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro anti-HIV-1 activity in cervicovaginal secretions from pregnant and nonpregnant women.
    Anderson BL; Ghosh M; Raker C; Fahey J; Song Y; Rouse DJ; Wira CR; Cu-Uvin S
    Am J Obstet Gynecol; 2012 Jul; 207(1):65.e1-10. PubMed ID: 22727351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans.
    Johansson EL; Wassén L; Holmgren J; Jertborn M; Rudin A
    Infect Immun; 2001 Dec; 69(12):7481-6. PubMed ID: 11705923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of secretory immunoglobulin A in cervicovaginal secretions of healthy women with an ELISA method].
    Mendling W; Metzger P
    Geburtshilfe Frauenheilkd; 1994 Jul; 54(7):417-20. PubMed ID: 7926576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of seminal antibodies to human immunodeficiency virus in vaginal secretions after sexual intercourse: possible means of preventing the risk of human immunodeficiency virus transmission in a rape victim.
    Bélec L; Matta M; Payan C; Tévi-Bénissan C; Meillet D; Pillot J
    J Med Virol; 1995 Jan; 45(1):113-6. PubMed ID: 7714486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of non-nucleoside reverse transcriptase inhibitors on cytokine, chemokine, and immunoglobulin profiles in serum and genital secretions of HIV-infected women.
    Sachdeva RK; Wanchu A; Bagga R; Malla N; Sharma M
    J Interferon Cytokine Res; 2010 May; 30(5):299-310. PubMed ID: 20187769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.